- Home
- KLTR vs INBX Comparison
KLTR vs INBX Comparison
Compare KLTR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- INBX
- Stock Information
- Founded
- KLTR 2006
- INBX 2010
- Country
- KLTR United States
- INBX United States
- Employees
- KLTR N/A
- INBX N/A
- Industry
- KLTR EDP Services
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- INBX Health Care
- Exchange
- KLTR Nasdaq
- INBX Nasdaq
- Market Cap
- KLTR 389.2M
- INBX 218.9M
- IPO Year
- KLTR 2021
- INBX 2020
- Fundamental
- Price
- KLTR $2.15
- INBX $12.74
- Analyst Decision
- KLTR Buy
- INBX Hold
- Analyst Count
- KLTR 2
- INBX 1
- Target Price
- KLTR $2.25
- INBX N/A
- AVG Volume (30 Days)
- KLTR 704.1K
- INBX 74.4K
- Earning Date
- KLTR 02-20-2025
- INBX 11-14-2024
- Dividend Yield
- KLTR N/A
- INBX N/A
- EPS Growth
- KLTR N/A
- INBX N/A
- EPS
- KLTR N/A
- INBX 119.38
- Revenue
- KLTR $177,586,000.00
- INBX $1,568,000.00
- Revenue This Year
- KLTR $3.34
- INBX N/A
- Revenue Next Year
- KLTR $1.88
- INBX N/A
- P/E Ratio
- KLTR N/A
- INBX $0.11
- Revenue Growth
- KLTR 1.62
- INBX 19.24
- 52 Week Low
- KLTR $0.76
- INBX $10.80
- 52 Week High
- KLTR $2.82
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- KLTR 47.46
- INBX 32.23
- Support Level
- KLTR $1.93
- INBX $13.57
- Resistance Level
- KLTR $2.82
- INBX $16.83
- Average True Range (ATR)
- KLTR 0.18
- INBX 0.94
- MACD
- KLTR -0.05
- INBX -0.21
- Stochastic Oscillator
- KLTR 24.72
- INBX 1.68
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.